Market Research Logo

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application (Oncology, Blood Disorders) - Global Forecast To 2021

The global biosimilars market is expected to reach USD 10.90 billion by 2021 from USD 3.39 billion in 2016, at a CAGR of 26.3%. The biosimilars market is broadly classified into product, manufacturing type, application, and region.

On the basis of product, the biosimilars market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins segment is estimated to account for the largest share of the biosimilars market, in 2016. Factors such as new product launches, cost-effectiveness, growing incidence of diabetes, and presence of many biosimilar versions of insulin in the pipeline are driving growth in this market.

On the basis of manufacturing type, the market is segmented into in-house manufacturing and contract manufacturing organizations. The contract manufacturing organizations segment is projected to witness the highest CAGR during the forecast period.

On the basis of application, the market is segmented into oncology, blood disorders, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases, and other applications. In 2016, the oncology segment is expected to account for the largest share of the market.

Geographically, the biosimilars market is dominated by Europe, followed by Asia, North America, and the Rest of the World (RoW). Growth in the European market is attributed to the growing pressure to curtail healthcare costs, patent expiry of biologics & the arrival of new biosimilars, and the rising incidence of chronic disorders.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

The key players in the biosimilars market include Pfizer Inc. (U.S.), Sandoz International GmbH (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Amgen Inc. (U.S.), Biocon Ltd. (India), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Celltrion Inc. (South Korea), and Samsung Bioepis (South Korea).

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the biosimilars market. The report analyses the biosimilars market by product, manufacturing type, and application.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the biosimilars market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the biosimilars market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various biosimilars products across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biosimilars market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKET COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN & DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
      • Table BIOSIMILARS MARKET SUMMARY
    • CONCLUSION
  • PREMIUM INSIGHTS
    • BIOSIMILARS: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: BIOSIMILARS MARKET, BY PRODUCT
    • BIOSIMILARS MARKET SIZE, BY APPLICATION, 2016 VS. 2021
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table BIOSIMILARS MARKET: MAJOR COLLABORATIONS (2012-2015)
      • RESTRAINTS
      • OPPORTUNITIES
        • Table LIST OF KEY BIOLOGICS UNDER THE THREAT OF PATENT EXPIRY
      • CHALLENGE
    • KEY PIPELINE PRODUCTS
      • Table BIOSIMILARS IN CLINICAL TRIALS
    • REGULATORY OUTLOOK
      • NORTH AMERICA
        • Table STATUS OF REGULATORY PATHWAY IN NORTH AMERICA
      • EUROPE
        • Table SUBSTITUTION STATUS IN EUROPEAN COUNTRIES
      • ASIA
        • Table STATUS OF REGULATORY PATHWAY IN ASIA
      • REST OF THE WORLD
        • Table STATUS OF REGULATORY PATHWAY IN THE ROW
    • BIOSIMILARS SERVICES INDUSTRY INSIGHTS
      • INTRODUCTION
      • CONTRACT MANUFACTURING ORGANIZATIONS
        • Table JOINT VENTURES BETWEEN CMOS & PHARMACEUTICAL COMPANIES FOR BIOSIMILARS
      • CONTRACT RESEARCH ORGANIZATIONS
      • OTHER SERVICES (NONCLINICAL & BIOINFORMATICS)
  • BIOSIMILARS MARKET, BY TYPE OF PRODUCT
    • INTRODUCTION
      • Table BIOSIMILARS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
    • RECOMBINANT NON-GLYCOSYLATED PROTEINS
      • Table BIOSIMILAR RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table BIOSIMILAR RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILAR RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILAR RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILAR RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • INSULIN
        • Table BIOSIMILAR INSULIN MARKET SIZE, BY REGION, 2014 -2021 (USD MILLION)
      • RECOMBINANT HUMAN GROWTH HORMONE (RHGH)
        • Table BIOSIMILAR RECOMBINANT HUMAN GROWTH HORMONE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • GRANULOCYTE COLONY-STIMULATING FACTOR (FILGRASTIM)
        • Table LIST OF APPROVED BIOSIMILARS FOR GRANULOCYTE COLONY-STIMULATING FACTOR PRODUCTS FROM 2013 TO 2016
        • Table BIOSIMILAR GRANULOCYTE COLONY-STIMULATING FACTOR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • INTERFERONS
        • Table BIOSIMILAR INTERFERONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • RECOMBINANT GLYCOSYLATED PROTEINS
      • Table BIOSIMILAR RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table BIOSIMILAR RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILAR RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILAR RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILAR RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • ERYTHROPOIETIN (EPO)
        • Table BIOSIMILAR ERYTHROPOIETIN MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • MONOCLONAL ANTIBODIES (MABS)
        • Table BIOSIMILAR MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • FOLLITROPIN
        • Table BIOSIMILAR FOLLITROPIN MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • RECOMBINANT PEPTIDES
      • Table BIOSIMILAR RECOMBINANT PEPTIDES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table BIOSIMILAR RECOMBINANT PEPTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILAR RECOMBINANT PEPTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILAR RECOMBINANT PEPTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILAR RECOMBINANT PEPTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • GLUCAGON
        • Table BIOSIMILAR GLUCAGON MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • CALCITONIN
        • Table BIOSIMILAR CALCITONIN MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • BIOSIMILARS MARKET, BY TYPE OF MANUFACTURING
    • INTRODUCTION
      • Table BIOSIMILARS MARKET SIZE, BY MANUFACTURING TYPE, 2014-2021 (USD MILLION)
    • IN-HOUSE MANUFACTURING
      • Table BIOSIMILARS MARKET SIZE FOR IN-HOUSE MANUFACTUIRNG, BY REGION, 2014-2021 (USD MILLION)
    • CONTRACT MANUFACTURING ORGANIZATIONS
      • Table BIOSIMILARS MARKET SIZE FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2014-2021 (USD MILLION)
  • BIOSIMILARS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table BIOSIMILARS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
    • ONCOLOGY
      • Table BIOSIMILARS MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD MILLION)
    • CHRONIC AND AUTOIMMUNE DISEASES
      • Table BIOSIMILARS MARKET SIZE FOR CHRONIC AND AUTOIMMUNE DISEASES, BY REGION, 2014-2021 (USD MILLION)
    • BLOOD DISORDERS
      • Table BIOSIMILARS MARKET SIZE FOR BLOOD DISORDERS, BY REGION, 2014-2021 (USD MILLION)
    • GROWTH HORMONE DEFICIENCY
      • Table BIOSIMILARS MARKET SIZE FOR GROWTH HORMONE DEFICIENCY, BY REGION, 2014-2021 (USD MILLION)
    • INFECTIOUS DISEASES
      • Table BIOSIMILARS MARKET SIZE FOR INFECTIOUS DISEASES, BY REGION, 2014-2021 (USD MILLION)
    • OTHER APPLICATIONS
      • Table BIOSIMILARS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • BIOSIMILARS MARKET, BY REGION
    • INTRODUCTION
      • Table BIOSIMILARS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: RECOMBINANT PEPTIDES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY MANUFACTURING TYPE, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table EUROPE: RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: RECOMBINANT PEPTIDES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILARS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: BIOSIMILARS MARKET SIZE, BY MANUFACTURING TYPE, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • FRANCE
        • Table FRANCE: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • U.K.
        • Table U.K.: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • ITALY
        • Table ITALY: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • SPAIN
        • Table SPAIN: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
    • ASIA
      • Table ASIA: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ASIA: RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA: RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA: RECOMBINANT PEPTIDES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILARS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table ASIA: BIOSIMILARS MARKET SIZE, BY MANUFACTURING TYPE, 2014-2021 (USD MILLION)
      • CHINA
        • Table CHINA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • INDIA
        • Table INDIA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • JAPAN
        • Table JAPAN: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • REST OF ASIA (ROA)
        • Table ROA: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: BIOSIMILARS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ROW: RECOMBINANT NON-GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: RECOMBINANT GLYCOSYLATED PROTEINS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: RECOMBINANT PEPTIDES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: BIOSIMILARS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • REGULATORY APPROVALS
        • Table REGULATORY APPROVALS, 2013-2016
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2013-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS
  • COMPANY PROFILES
    • INTRODUCTION
    • PFIZER INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • SANDOZ INTERNATIONAL GMBH (A DIVISION OF NOVARTIS INTERNATIONAL AG)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AMGEN INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOCON LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • DR. REDDY'S LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • CELLTRION INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MYLAN INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SAMSUNG BIOEPIS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report